The QualityStocks Daily Tuesday, May 7th, 2019

Today's Top 3 Investment Newsletters

TopPennyStockMovers (IPIX) +89.12%

StreetInsider (COHU) +24.18%

MarketBeat (SEDG) +22.70%

The QualityStocks Daily Stock List

Harvest Health & Recreation, Inc. (HRVSF)

Midas Letter, Cannabis Stock Trades, Cannabis Business Times, Micro Cap Daily, New Cannabis Ventures, Proactive Investors, InvestorsHub, Profit Confidential, Market Watch, and Stockhouse reported previously on Harvest Health & Recreation, Inc. (HRVSF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A vertically-integrated cannabis company, Harvest Health & Recreation, Inc. has one of the largest and deepest footprints in the United States. The Company is a multi-state cannabis operator (MSO). Its corporate mission is to improve lives through the goodness of cannabis. Harvest Health & Recreation is centered on its vision to become the most valuable cannabis company globally. OTCQX-listed, the Company is based in Tempe, Arizona.

Harvest Health & Recreation's total vertical solution includes industry-leading cultivation, manufacturing, and retail facilities, construction, real estate, technology and operational expertise -taking advantage of in-house legal, HR and marketing teams, along with proven experts in writing and winning State-based applications. Since 2011, the Company's dedication has been to aggressively expanding its Harvest House of Cannabis retail and wholesale presence throughout the U.S., acquiring, creating and growing top brands for patients and consumers nationally, and continuing on a course of profitable growth.

Subject to the completion of announced acquisitions, Harvest Health & Recreation will have the largest footprint in the U.S., with rights to 219 facilities, of which 142 are retail locations and greater than 1,580 employees across 17 States. The Company presently operates or has rights to operate in cannabis facilities or expects to have rights to acquire licenses following the closings of recently announced acquisitions in Arizona, Arkansas, California, Delaware, Florida, Illinois, Maryland, Massachusetts, Michigan, New Jersey, Nevada, North Dakota, Ohio, Oklahoma, Pennsylvania and Puerto Rico.

Last month, Harvest Health & Recreation announced it entered into a binding, definitive agreement to acquire CannaPharmacy, Inc., subject to satisfaction of customary closing conditions. This includes receipt of regulatory approvals in the relevant States. CannaPharmacy owns or operates (via management companies) cannabis licenses in Pennsylvania, Delaware, New Jersey, and Maryland. It also holds a minority interest in a pending licensee in Colombia. Harvest Health & Recreation expects that the transaction will be accretive to the Company's 2020 revenue and EBITDA.

Harvest Health & Recreation would become the largest MSO in the U.S. following closing of a definitive agreement signed on April 22, 2019 to acquire Verano Holdings, LLC, as earlier announced by a press release dated March 11, 2019. Verano is one of the largest privately held multi-state, vertically integrated licensed operators of cannabis facilities with a wide-ranging portfolio of premium branded products.

Mr. Steve White, Chief Executive Officer of Harvest Health & Recreation, will deliver a Keynote Address, entitled: "Cannabis Investing Today and Tomorrow: Cutting through the Chatter and Focusing on Basic Financials/Growth Strategies," at the 6th Annual Cannabis World Congress & Business Exposition (CWCBExpo) taking place May 29 – June 1, 2019, at the Javits Center in New York, New York.

Harvest Health & Recreation, Inc. (HRVSF), closed Tuesday's trading session at $8.09, down 1.10%, on 620,413 volume with 2,198 trades. The average volume for the last 3 months is 395,157 and the stock's 52-week low/high is $0.075/$10.85.


HIVE Blockchain Technologies Ltd. (HVBTF)

Micro Small Cap, TipRanks, Blockchain Stocks, FXStreet, Invest Tribune, Stockwatch, 4-Traders, Market Screener, Trading View, Insider Financial, Stockhouse, Simply Wall St, Smarter Analyst, Crypto141, Dividend Investor, Wallmine, Investors Hangout, InvestorsHub, and YCharts reported earlier on HIVE Blockchain Technologies Ltd. (HVBTF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

HIVE Blockchain Technologies Ltd. is a company building a bridge from the blockchain sector to traditional capital markets. The Company is strategically partnered with Genesis Mining Ltd. to build the next generation of blockchain infrastructure. HIVE's corporate mission is to speed up the development of the blockchain sector via traditional capital markets and create long-term shareholder value. The Company's shares trade on the OTC Markets Group's OTCQX. HIVE Blockchain Technologies has its head office in Vancouver, British Columbia.

The Company's deployments provide shareholders with exposure to the operating margins of digital currency mining and an increasing portfolio of crypto-coins. HIVE owns state-of-the-art GPU-based digital currency mining facilities in Iceland and Sweden that produce newly minted digital currencies such as Ethereum continuously as well as a cloud-based ASIC-based capacity that produces newly minted digital currencies such as Bitcoin.

HIVE Blockchain Technologies has an exclusive arrangement with Genesis Mining to operate its data centers under a Master Service Agreement. The data centers will be monitored with Genesis Hive, which is Genesis Mining's proprietary software tool for large-scale mining, to automatically optimize chip temperatures and power consumption for maximal coin production.

Regarding the Iceland Cryptocurrency Mining Project, HIVE's launch transaction involved the acquisition of an initial state-of-the-art blockchain infrastructure facility in Iceland from Genesis Mining. This facility produces mined cryptocurrency around the clock. Assembly of the facility, which uses innovative computing components and infrastructure design, was completed in May of 2017. In Sweden, HIVE's GPU facilities were completed in April 2018 and are equipped with custom Genesis A2 mining rigs.

HIVE Blockchain Technologies launched the operation of an additional 100 PH of cloud-based ASIC Bitcoin mining on December 1, 2018. This brings the Company's digital currency mining footprint to a total of 24.2 MW of GPU mining and 300 PH of ASIC capacity.

In April, HIVE Blockchain Technologies advised that on April 19, 2019, Genesis Mining, the largest shareholder of the Company, holding roughly 26.3 percent of HIVE's outstanding shares, requisitioned a meeting of shareholders for the purpose of removing directors independent of Genesis and electing a Board of Directors, the majority of whom would be senior officers and employees of Genesis Mining. On April 20, 2019, the HIVE Board met and appointed an independent Special Committee of the Board to deal with the requisition and related contractual disputes between Genesis and HIVE that gave rise to the requisition. HIVE stated the Special Committee will act in the interests of all HIVE shareholders and the Special Committee will set a date for the requisitioned meeting to be held within four months of proper delivery of the requisition notice.

HIVE Blockchain Technologies Ltd. (HVBTF), closed Tuesday's trading session at $0.386, down 3.50%, on 751,851 volume with 243 trades. The average volume for the last 3 months is 532,273 and the stock's 52-week low/high is $0.17/$1.09.


Repro Med Systems, Inc. (REPR)

Marketbeat, Zacks, Infront Analytics, Streetwise Reports, Market Screener, Wallmine, InvestorsHub, Wallet Investor, Simply Wall St, Business Wire, Equity Clock, Dividend Investor, Stockwatch, Capital Cube, and Stockhouse reported earlier on Repro Med Systems, Inc. (REPR), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Repro Med Systems, Inc. does business as RMS Medical Products (REPR) (RMS Medical). RMS Medical develops, manufactures and commercializes unique and user-friendly specialty infusion solutions, which improve quality of life for patients worldwide. Repro Med Systems has its corporate headquarters in Chester, New York.

The FREEDOM Syringe Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, RMS Precision Flow Rate Tubing™ and RMS HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in the home and alternate care settings. The Company sells its products by way of direct sales and medical device distributors, and also online.

In April, Repro Med Systems announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its HIgh-Flo Super26™ Subcutaneous Needle Sets (Super 26 Needle Sets). The Super26 Needle Sets are indicated for subcutaneous infusion of medications in the home, hospital, or ambulatory settings to facilitate high flow rates. This includes human plasma-derived immunoglobulins such as Hizentra® and Cuvitru™.

Expanding on RMS Medical's well-regarded lineup of HIgH-Flo needle sets, the Super26 Needle Sets use a proprietary design to provide 26-gauge comfort with considerably faster flow rates. Mr. Don Pettigrew, President and Chief Executive Officer of Repro Med Systems, said, "This clearance reflects our commitment to broadening RMS Medical's product portfolio with solutions that optimize the delivery and efficacy of subcutaneous therapies, promote compliance, and improve the overall patient experience. The Super26 Needle Sets support the shift towards faster SCIg infusions while addressing patient comfort concerns via the use of a smaller diameter needle. This could be very helpful in existing and new indications where large volumes of drugs are required to be infused."

Last week, Repro Med Systems, Inc. dba RMS Medical Products announced financial results for the three months ended March 31, 2019 (Q1 2019). Net Sales increased 23.3 percent from the previous year to $5.0 million. This represents a quarterly record. Net Sales were mainly driven by the Company's emphasis on expanding its base of national accounts, growth in the PIDD market, and expansion into the neurology market following the 2018 approval of Hizentra® to treat CIDP.

Repro Med Systems, Inc. (REPR), closed Tuesday's trading session at $1.6044, down 0.96%, on 19,800 volume with 16 trades. The average volume for the last 3 months is 26,963 and the stock's 52-week low/high is $1.115/$1.79.


Aleafia Health, Inc. (ALEAF)

Stock Gumshoe, Green Market Report, Micro Cap Daily, Micro Small Cap, CannabisMarketCap, The Cannabis Investor, New Cannabis Ventures, Insider Financial, Pot Stock News, Stockhouse, Proactive Investors, Profit Confidential, Small Cap Power, Midas Letter, Trading View, Stockwatch, InvestorsHub, and Wallet Investor reported earlier on Aleafia Health, Inc. (ALEAF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Aleafia Health, Inc. is a foremost, vertically integrated cannabis health and wellness company headquartered in Concord, Ontario. It has four primary business units: Cannabis Cultivation & Products, Health & Wellness Clinics, Cannabis Education, and Consumer Experience with ecommerce, retail distribution and provincial supply agreements. The Company produces a varied portfolio of commercially proven, high-margin derivative products including oils, capsules and sprays. Aleafia Health's shares trade on the OTC Markets Group's OTCQX.

Furthermore, the Company owns three major cannabis product and cultivation facilities. Two of these are licensed and operational. Aleafia Health has been named the 2019 top performing company of the year by the TSX Venture Exchange.

Aleafia operates the largest national network of medical cannabis clinics and education centers staffed by MDs, nurse practitioners and educators. The Company maintains a medical cannabis dataset with greater than 10 million data points to inform proprietary illness specific product development and treatment best practices.

Following the expected expansion of the three Aleafia Health production facilities, together with confirmed supply agreements, the Company expects to reach an annual production capacity of 138,000 kg of dried flower, and extraction capacity of 50,000 kg. Its modern, automated Niagara Greenhouse is now in a plant-ready state. Complete construction and retrofitting of the facility is expected to be completed this month.

Today, Aleafia Health announced it is entering the German medical cannabis market by way of its joint venture (JV) with German pharmaceutical wholesaler Acnos Pharma GmbH. The JV entity will purchase Aleafia Health branded cannabis oils for distribution to German pharmacies and for clinical trial usage.

Aleafia Health's wholly-owned subsidiary Emblem Cannabis Corp. is the majority shareholder of the JV with 60 per cent ownership with Acnos Pharma owning the remaining 40 per cent. Acnos is an Aachen & Berlin-based pharmaceutical wholesaler and distribution logistics company that specializes in branded prescription pharmaceuticals, controlled drugs, as well as clinical trial supply.

Aleafia Health, Inc. (ALEAF), closed Tuesday's trading session at $1.2777, up 4.90%, on 1,147,719 volume with 1,166 trades. The average volume for the last 3 months is 589,262 and the stock's 52-week low/high is $0.387/$3.62.


Anvia Holdings Corporation (ANVV)

Stock Target Advisor, GlobeNewswire, MarketWatch, Barchart, Simply Wall St, GuruFocus, Stockhouse, Trading View, Market Screener, Last10k, Stockwatch, Wallet Investor, Dividend Investor, and InvestorsHub reported beforehand on Anvia Holdings Corporation (ANVV), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Anvia Holdings Corporation is an international technology for self and business improvement company. It has acquired and developed a number of proprietary software, mobile applications, learning and educational tools to help consumers and businesses improve and grow. The Company's mission is to make personal and business growth accessible and sustainable.

The Company was previously known as Dove Street Acquisition Corporation. It changed its name to Anvia Holdings Corporation in January of 2017. Founded in 2016, Anvia Holdings is headquartered in Glendale, California.

The Anvia business and organizational portfolio comprises software and mobile application technologies, consulting services, coaching services, and blended learning content and activities. Some of the areas it serves its business clients are Strategy Management, Competency Management, Performance Management, Learning Management, Customer Experience Management, Franchise, Corporate Advisory and Listing, and HR Information Systems.

Last week, Anvia Holdings announced that it executed a definitive agreement to acquire all of the issued and outstanding shares of XSEED Pty Ltd, an Australian Registered Training Organization. With this agreement, Anvia Holdings, via its fully-owned subsidiary Anvia (Australia) Pty Ltd shall acquire 100 percent of XSEED Pty Ltd outstanding shares for approximately USD 352,000 (AUD 500,000). XSEED engages in the provision of vocational education training (VET) and offers courses that are for the Automotive and Hairdressing industries.

Anvia (Australia) Pty Ltd Chief Executive Officer, Mr. James Kennett, said "Adding XSEED to our education services portfolio solidifies our position in Australia as a major player in Education Services. In addition, XSEED will diversify our current CRICOS and Corporate learning income with further revenue sources."

Moreover, last week, Anvia Holdings announced it filed an application to list its common shares on the NASDAQ Capital Market.

Ali Kasa, Chief Executive Officer and President of Anvia Holdings, said, "The listing of our common shares on NASDAQ would reflect the progress we are making to strengthening our corporate governance and mark another significant milestone in our quest to become a global leader in the self and business improvement industry."

Anvia Holdings Corporation (ANVV), closed Tuesday's trading session at $4.8405, up 2.99%, on 7,408 volume with 33 trades. The average volume for the last 3 months is 77,040 and the stock's 52-week low/high is $0.51/$6.00.


NervGen Pharma Corp. (NGENF)

Stock Target Advisor, Investor Ideas, Investorx, Investors Hangout, Stockhouse, MarketWatch, Trading View, and Market Screener reported on NervGen Pharma Corp. (NGENF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

NervGen Pharma Corp. is a regenerative medicine company listed on the OTC Markets Group's OTCQB. Its commitment is to creating ground-breaking solutions for the treatment of nerve damage. This includes spinal cord and peripheral nerve injury. The Company's lead compound is NVG-291. NervGen Pharma has its corporate headquarters in Vancouver, British Columbia.

In addition, the Company continues to research secondary applications such as multiple sclerosis, acute myocardial infarction induced arrhythmia (AMI, commonly known as a heart attack), stroke and other neurodegenerative diseases.

NervGen Pharma's plan is to start a Phase 1 human clinical trial for its lead compound, NVG-291, in early 2020 under an Investigational New Drug application with the US Food and Drug Administration (FDA). The Company is advancing NVG-291 for the treatment of spinal cord injury as it believes this indication is a major opportunity because of the current lack of non-surgical solutions in the market, the significant impact on quality of life, and the high cost burden to the healthcare system.

NervGen's belief is that NVG-291 as a therapy could alleviate or improve upon the symptoms and conditions associated with spinal cord injury. It also believes that NVG-291 as a therapy could empower these patients to live more active and productive lives.

NervGen Pharma's core technology targets protein tyrosine phosphatase sigma (PTPσ). This is a neural receptor that impedes nerve regeneration. Inhibition of the PTPσ receptor has been shown to promote regeneration of damaged nerves and improvement of nerve function in animal models for different medical conditions. Research has been conducted on other applications of PTPs including MS, stroke, cardiac arrhythmia, and Alzheimer's Disease.

Last week, NervGen Pharma announced that in addition to trading on the TSX Venture Exchange, its common shares started trading on the OTCQB Venture Market on Friday, May 3, 2019 under the symbol "NGENF".

Mr. Bill Radvak, Executive Chairman of NervGen Pharma, said, "The commencement of trading in the United States is an important step in our corporate plan to increase awareness with the broader financial community and generate more share liquidity."


NervGen Pharma Corp. (NGENF), closed Tuesday's trading session at $1.38049, down 1.39%, on 6,170 volume with 14 trades. The average volume for the last 3 months is 12,040 and the stock's 52-week low/high is $1.18/$1.462.


ImageWare Systems, Inc. (IWSY)

Super Stock Screener, Equity Clock, Insider Financial, Zacks, Street Insider, Wallet Investor, Marketbeat, Simply Wall St, InvestorsHub, Wallmine, 4-Traders, Stockopedia, TipRanks, Market Screener, Insider Tracking, and Infront Analytics reported earlier on ImageWare Systems, Inc. (IWSY), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed, ImageWare Systems, Inc. is a leader in mobile and cloud-based, multi-modal biometric identity management solutions. The Company provides two-factor, biometric and multi-factor cloud-based authentication solutions for the enterprise. ImageWare serves healthcare, banking, retail/e-commerce, government, as well as law enforcement and public safety markets. Formed in 1987, ImageWare Systems has its head office in San Diego, California. It also has offices in Oregon, Canada, Mexico, and Japan.

ImageWare Systems delivers next-generation biometrics as an interactive and scalable cloud-based solution. The Company brings together cloud and mobile technology to offer two-factor, biometric, and multi-factor authentication for smartphone users, for the enterprise, and across industries. Its products support multi-modal biometric authentication including, but not limited to, face, voice, fingerprint, iris, palm, and more.

All of the biometrics can be combined with or used as replacements for authentication and access control tools (including tokens, digital certificates, passwords, and PINS) to provide the supreme level of assurance, accountability, and user-friendliness for corporate networks, web applications, mobile devices, as well as PC (Personal Computer) desktop environments.

Recent significant events for ImageWare Systems include introducing the ImageWare Digital Identity Platform ™, an end-to-end digital biometric identity proofing, authentication and lifecycle management solution. This platform provides the widest set of identity validation and biometric authentication capabilities in the industry.

Moreover, this past February, ImageWare Systems announced an agreement in an 8-K filing that an international financial services provider selected ImageWare to provide multi-modal biometric authentication solutions for a healthcare application (used to comply with mandates under the 21st Century Cures Act).

Furthermore, in March, in an 8-K filing, the Company announced a contract award via its partner Contactable, to provide biometric authentication to a major multinational mobile telecommunications company. Additionally, ImageWare Systems' GVID Biometric Platform was chosen to secure worldwide cloud authentication for Also, Gatekeeper Innovation and ImageWare announced a partnership to address the opioid epidemic and improve patient outcomes.

ImageWare Systems, Inc. (IWSY), closed Tuesday's trading session at $1.35, even for the day, on 95,557 volume with 71 trades. The average volume for the last 3 months is 161,085 and the stock's 52-week low/high is $0.55/$1.79.


Q BioMed, Inc. (QBIO)

NetworkNewsWire, Market Screener, Zacks, Insider Financial, TipRanks, MarketWatch, Proactive Investors, InvestorsHub, Simply Wall St, Wallet Investor, and Stockhouse reported previously on Q BioMed, Inc. (QBIO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A biomedical acceleration and development enterprise, Q BioMed, Inc. concentrates on licensing, acquiring, and providing resources to life sciences and healthcare companies. It acquires, develops and finances undervalued biomedical assets. The Company's corporate mission is to create a pipeline of unique biomedical assets in diverse stages of development in multiple therapeutic areas. The Company states that its strategy will minimize risk, share success and accelerate its technologies from incubation to monetization. OTCQB-listed, Q BioMed is headquartered in New York, New York.

The Company believes its assets in oncology, vascular disease, and rare orphan diseases address unmet medical needs and large markets. The expectation is that its Food and Drug Administration (FDA) approved, non-opioid drug Metastron, which relieves cancer bone pain, will start generating revenues this year. Additionally, Metastron is approved for sale in 21 other countries.

In addition to treating pain, Metastron has exhibited evidence of treating the cancer itself and extending survival. Q BioMed plans to conduct Phase IV trials to support label extension and cancer survival benefit using Metastron. The Company's growing pipeline also includes QBM-001 (Rare Pediatric Non-Verbal Autism Spectrum Disorder); UTTROSIDE-B (Chemotherapeutic For Liver Cancer); and MAN-01 (Topical Eyedrops For Glaucoma).

In April, Q BioMed announced the discovery of two novel biomarkers for pediatric nonverbal autism, identified in a subset of children with Autism Spectrum Disorder (ASD). This marks the first time a company has been able to identify biomarkers, which hold the potential to stratify this subset of children. The study took into consideration 1,953 potential biomarkers and used Vineland II scores to stratify 240 children into three groups: verbal, semi-verbal, and nonverbal autism.

Q BioMed Chief Executive Officer, Denis Corin, said, "This is a major breakthrough for these children and their families. To date, very little attention and research has been focused on these nonverbal autistic children. In partnership with the clinical and advocacy community, Q BioMed is leading the effort to better stratify this group, while also pursuing a treatment."

Q BioMed, Inc. (QBIO), closed Tuesday's trading session at $1.62, down 2.41%, on 21,370 volume with 49 trades. The average volume for the last 3 months is 46,304 and the stock's 52-week low/high is $0.89/$3.65.


Flower One Holdings, Inc. (FLOOF)

Cash Crop Today, Pot Stock News, Market Beat, Street Insider, Investor Ideas, Stockwatch, Investors Hangout, Invest Tribune, Investing News, Trading View, Dividend Investor, Stockhouse, New Cannabis Ventures, InvestorsHub, and MarketWatch reported previously on Flower One Holdings, Inc. (FLOOF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Flower One Holdings, Inc. is on the fast track to becoming the foremost cannabis cultivator, producer and innovator in Nevada. The Company owns and operates a 25,000 square-foot cultivation and production facility in North Las Vegas, with nine grow rooms. In addition, it owns the established NLV Organics consumer brand of cannabis products. Flower One Holdings lists on the OTC Markets' OTCQB and the Company is headquartered in Toronto, Ontario.

Flower One is completely licensed for medical marijuana cultivation and production, and also recreational marijuana cultivation and production in Nevada. At present, the Company holds licensing agreements with its Brand Partners - Flyte Concentrates, Rapid-Dose Therapeutics' Quick Strip, Old Pal, Palms, HUXTON, CannAmerica Brands, Grenco Science (G Pen), and The Medicine Cabinet.

Furthermore, Flower One Holdings is quickly converting its 455,000 square-foot greenhouse and production facility for cultivating and processing high-quality cannabis at scale. This facility is the largest in the State of Nevada. Combined, the flagship greenhouse facility and production facility (once totally operational) and the North Las Vegas facility provide the Company with 480,000 square feet of capacity for cultivation and processing, production and high-volume packaging of dry flower, cannabis oils, concentrates and infused products.

In April, Flower One announced that the conversion of its greenhouse was 95 percent complete. The greenhouse is now greater than 60 percent canopied. Five of eight zones are fully planted. Additionally, the greenhouse's high-tech cutting cell rooms and three expansive, multi-density vegetative zones are fully populated.

Flower One anticipates that its inaugural Zone One harvest will start next month. Upon being completely canopied, the Company should be capable of producing more than 140,000 lbs (or 62,500 kg) of dry flower annually and will house in the eight flower zones more than 80,000 plants per crop cycle.

The construction of Flower One's production facility is progressing. It has now completed the buildout of the initial 15,000 square feet of this facility. This includes a fully automated wetting line, pruning line and two high-tech cutting cell rooms. The exterior construction of the additional 40,000 square foot, two-story structure was completed in March of this year.

Flower One Holdings, Inc. (FLOOF), closed Tuesday's trading session at $2.2834, up 1.94%, on 46,054 volume with 70 trades. The average volume for the last 3 months is 144,377 and the stock's 52-week low/high is $0.88/$2.81.


Nutriband, Inc. (NTRB)

Simply Wall St, Market News Updates, Investing Online, Market Screener, Barchart, Stockhouse, Wallet Investor, Trading View, InvestorsHub, Financial Content, 4-Traders, Seeking Alpha, and MarketWatch reported previously on Nutriband, Inc. (NTRB), and today we report on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Nutriband, Inc. chiefly engages in the development of a portfolio of transdermal pharmaceutical products. The Company's lead product under development is its abuse deterrent fentanyl transdermal system. Nutriband's mission is to use Transdermal Technology to improve patient comfort and efficacy and to take existing transdermal treatments and replace them with safer new alternatives. A Nevada Corporation, Nutriband has its corporate office in Orlando, Florida.

The Company is developing the abuse deterrent fentanyl transdermal system to provide clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy combined with properties designed to help fight the opioid crisis through deterring the abuse and misuse of fentanyl patches.

A key Nutriband emphasis and area of expertise is in the development of transdermal products for currently injected compounds. This includes proteins, peptides, macromolecules, as well as biologics. Nutriband has capabilities for developing pharmaceutical products from pre-clinical testing to clinical manufacturing and early stage clinical development (Phase I/II).

Last month, Nutriband announced that the Japan Patent Office granted complete patent protection for the Japanese Patent Application entitled, "Abuse and Misuse Deterrent Transdermal System" submitted by its subsidiary, 4P Therapeutics. The patent relates to the Company's proprietary abuse deterrent transdermal technology, utilized in the fentanyl transdermal system that is undergoing development at 4P Therapeutics to battle the opioid epidemic. The news follows the March 2019 decision by the European Patent Office to grant European Patent Protection on the same technology.

4P Therapeutics (Corners, Georgia) is a wholly-owned subsidiary of Nutriband Inc. 4P's focus is on the research and development (R&D) of novel drug delivery technologies and therapeutics. 4P Therapeutics develops products that meet the needs of patients, physicians, and also payers. 4P Therapeutics has developed the Defent™ abuse deterrent patch technology to deter abuse of fentanyl patches via the oral, buccal and inhaled routes that represent as much as 70 percent of all transdermal fentanyl abuse.

Nutriband, Inc. (NTRB), closed Tuesday's trading session at $8.49, down 0.70%, on 405 volume with 3 trades. The average volume for the last 3 months is 806 and the stock's 52-week low/high is $4.01/$12.70.


Amplify Energy Corp. (AMPY)

Zacks, Morningstar, Simply Wall St, Market Screener, Wallet Investors, and 4-Traders reported earlier on Amplify Energy Corp. (AMPY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Amplify Energy Corp. is an independent oil and natural gas company listed on the OTC Markets Group's OTCQX. The Company engages in the acquisition, development, exploration and production of oil and natural gas properties. Its properties comprise mature, legacy oil and natural gas fields. Amplify Energy has its corporate office in Houston, Texas.

The Company's operations are centered in the Rockies, offshore California, East Texas/North Louisiana and South Texas. Amplify Energy's emphasis is maintaining production across its high-quality asset base and executing on its strategic priorities.

Its properties chiefly comprise operated working interests (WIs) in producing and undeveloped leasehold acreage and in identified producing wells in North America. In addition, Amplify Energy owns non-operated working interests in producing and undeveloped leasehold acreage. Most of its oil and natural gas properties are situated in large, mature oil and natural gas reservoirs with well-known geologic characteristics and long-lived, predictable production profiles and modest capital requirements.

Today, Amplify Energy and Midstates Petroleum Company, Inc. (MPO) announced that they entered into a definitive merger agreement pursuant to which Amplify Energy will merge with a subsidiary of Midstates in an all-stock merger-of-equals. With this merger agreement, Amplify Energy stockholders will receive 0.933 shares of newly issued Midstates Petroleum Company common stock for each Amplify share of common stock. The expectation is that the merger will close in Q3 of 2019. At that time Amplify Energy and Midstates Petroleum stockholders will each own 50 percent of the outstanding shares of the combined company.

Midstates Petroleum Company is an independent exploration and production company. It centers on the application of modern drilling and completion techniques in oil- and liquids-rich basins in the onshore U.S. Its operations are presently focused on oilfields in the Mississippian Lime play in Oklahoma.

Last week, Amplify Energy announced that it will report its Q1 2019 financial and operating results on Thursday, May 9, 2019. Following the announcement, Company Management will host a conference call at 10:00 a.m. CT to discuss Amplify's results.

Amplify Energy Corp. (AMPY), closed Tuesday's trading session at $9.53, down 1.75%, on 142,966 volume with 77 trades. The average volume for the last 3 months is 18,663 and the stock's 52-week low/high is $6.51/$11.50.


Acro Biomedical Co., Ltd. (ACBM)

Wallmine, Dividend Investor, Stockhouse, Trading View, Central Charts, Interactive Brokers, Wallet Investor, Simply Wall Street, Market Screener, and Stockopedia reported earlier on Acro Biomedical Co., Ltd. (ACBM), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Acro Biomedical Co., Ltd. concentrates on developing and marketing products that promote wellness and a healthy lifestyle. Its intention is to conduct research and development (R&D) on its own proprietary products based on cordyceps sinensis. Cordyceps is a fungus used in traditional Chinese medicine (TCM). Acro Biomedical lists on the OTC Markets' OTCQB.

The Company previously went by the name Killer Waves Hawaii, Inc. It changed its corporate name to Acro Biomedical Co., Ltd. in January of 2017. Acro Biomedical Co., Ltd. was established in 2014 and is headquartered in Fishers, Indiana.

The above-mentioned Cordyceps sinensis has been described as a medicine in old Chinese medical books and Tibetan medicine. It is a rare combination of a caterpillar and a fungus and found at altitudes above 4500m in Sikkim. Acro Biomedical sells cordycepin and cordyceps powder, a fungus used in traditional Chinese medicine; and metallothionein MT-3 elizer, a protein powder used in health supplements.

Acros' business model is primarily using advanced core technology and materials to assist enterprises in developing competitive goods. In addition, the Company engages in new drug development projects in the U.S. and China and proposed development strategies to integrate the Chinese market in new situations, breaking through the risk of high cost and long times. Acro Biomedical will operate in two chief areas – health food development and new drug development.

For full Fiscal 2018, Acro Biomedical generated Revenue of $8.0 million. It realized record Gross Profit in fiscal year 2018 of $0.83 million. Furthermore, it generated positive Net Income of $0.42 million.

Acro Biomedical may also seek to market other products that it sees as complementary to its current products. Pao-Chi Chu, Acro Biomedical's Chief Executive Officer, said, "We believe that our Revenue and Net Income for the year ended September 30, 2018 show that there is a market for our products. We are hoping to expand our customer base and work on product development during the current year."

Acro Biomedical Co., Ltd. (ACBM), closed Tuesday's trading session at $5.80, up 10.48%, on 1,509 volume with 5 trades. The average volume for the last 3 months is 3,570 and the stock's 52-week low/high is $2.27/$6.25.


Copper Mountain Mining Corporation (CPPMF)

Streetwise Reports, YCharts, Stockwatch, The Online Investor, MarketWatch, Street Insider, Teletrader, Barchart, Stockhouse, Trading View and Wallet Investor reported previously on Copper Mountain Mining Corporation (CPPMF), and we report on the Company as well, her at the QualityStocks Daily Newsletter.

Listed on the OTC Markets, Copper Mountain Mining Corporation operates as a mining company in Canada. It explores for copper, gold, and silver deposits. The Company's flagship asset is the 75 percent owned Copper Mountain mine situated in southern British Columbia near the town of Princeton. Established in 2006, Copper Mountain Mining is based in Vancouver, British Columbia.

At present, the Copper Mountain mine produces roughly 90 million pounds of copper equivalent, with average annual production expected to increase to greater than 110 million pounds of copper equivalent next year. In addition, Copper Mountain Mining has the permitted, development-stage Eva Copper Project in Queensland, Australia. It also has a wide-ranging 4,000 km2 highly prospective land package in the Mount Isa region.

With a modest mill expansion and integration of New Ingerbelle, the expectation is that the Copper Mountain mine will have a 26 year mine life and produce an average of 116 million pounds of copper equivalent per year. Moreover, the permitted development-ready Eva Copper Project in Queensland, Australia is expected to contribute an additional roughly 100 million pounds of copper equivalent per year when in production.

This past February, Copper Mountain Mining announced a new integrated life of mine production plan for its Copper Mountain Properties in southern British Columbia. The Integrated Production Plan includes a modest expansion of the existing Copper Mountain Mine (CMM) mill to 45,000 tonnes per day (tpd) and integrates production from New Ingerbelle.

The results include a 102 percent increase in Mineral Reserves, a 27 percent increase in average annual copper equivalent production to 116 million pounds (over the first ten years), a 12-year extension in mine life to the aforementioned 26 years and a decrease in C1 cash costs to US$1.87 per pound produced, when compared to the prior CMM production plan included in the Company's 2018 NI 43-101 Technical Report for the Copper Mountain Mine, filed in November of last year.

Last week, Copper Mountain Mining announced that Production for Q1 of 2019 was 22.3 million pounds of copper equivalent (consisting of 18.6 million pounds of copper, 7,127 ounces of gold and 62,280 ounces of silver). Revenue for Q1 of 2019 was $86.9 million, 11 percent higher than Q1 of 2018, from the sale of 19.3 million pounds of copper, 7,026 ounces of gold and 64,992 ounces of silver, net of pricing adjustments. C1 cash cost per pound of copper produced was US$1.77 for Q1 of 2019. This represents a 9.7 percent reduction from Q1 of 2018.

Copper Mountain Mining Corporation (CPPMF), closed Tuesday's trading session at $0.71616, down 2.23%, on 104,330 volume with 53 trades. The average volume for the last 3 months is 25,727 and the stock's 52-week low/high is $0.48/$1.12.


Concierge Technologies, Inc. (CNCG)

Stock Gumshoe, Stock News Now, Equity Clock, Investor Point, Market Exclusive, Marketbeat, Stockhouse, Wallmine, Real Investment Advice, Trading View, Market Screener, Wallet Investor, and Stockopedia reported earlier on Concierge Technologies, Inc. (CNCG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Concierge Technologies, Inc. is a worldwide holding firm, with operating subsidiaries in financial services, food manufacturing, security systems and beauty products. The Company's offices and manufacturing operations are in the United States, New Zealand and Canada. Concierge Technologies' goal is to acquire other diverse companies that are established, profitable, have in-place management teams, sustainable business models and can be purchased for a fair price. Concierge Technologies is headquartered in San Clemente, California.

The Company, via its subsidiaries, produces, packs, and distributes meat pies and related bakery confections to the groceries, gasoline convenience stores, and independent retailers in the United States, New Zealand, and Canada. In addition, it engages in the provision of security alarm system installation and monitoring services; and wholesale distribution of hair and skin care products under the brand name Original Sprout. Concierge Technologies' subsidiaries include Brigadier Security Systems, Ltd. (Saskatoon, Saskatchewan); Gourmet Foods, Ltd. (Tauranga, New Zealand); Original Sprout; and USCF (Walnut Creek, California).

This past March, Concierge Technologies announced that its wholly-owned subsidiary, Brigadier Security Systems, was certified by the Underwriters' Laboratories of Canada (ULC) as a qualified installer of ULC-approved fire alarm panel communication systems. Only ULC-certified installers are allowed to install communication panels and provide monitoring services to all commercial buildings in Canada, which are required by law to have such systems in place.

In April, Concierge Technologies announced that its wholly-owned subsidiary, Original Sprout, is partnering with Ugly Industries Holdings, LLC and their imminent theatrical release of the animated musical adventure ''UglyDolls'' from STXfilms, which was due to be in theaters on May 3, 2019. Original Sprout announced its partnership with the upcoming release. Original Sprout customers have been invited to enter an on-line Sweepstakes from April 15 to May 15, 2019, where they will be able to win different prizes featuring ''UglyDolls'' promotional items. Original Sprout offers a complete line of ''Worry-Free'', 100 percent vegan, hair and body products for the entire family.

Concierge Technologies, Inc. (CNCG), closed Tuesday's trading session at $1.00, even for the day, on 250 volume with 1 trade. The average volume for the last 3 months is 752 and the stock's 52-week low/high is $0.55/$1.85.


The QualityStocks Company Corner

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

Gene therapies are gaining growing attention within the medical sector. Genprex Inc. (NASDAQ: GNPX) is developing gene therapies for the treatment of cancer, including its initial drug candidate, Oncoprex(TM) immunogene therapy.

Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (NASDAQ: GNPX), closed the day's trading session at $1.7799, up 1.13%, on 6,299 volume with 45 trades. The average volume for the last 3 months is 46,252 and the stock's 52-week low/high is $0.95/$18.44.

Recent News


Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)

The QualityStocks Daily Newsletter would like to spotlight Wildflower Brands Inc. (WLDFF).

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) continues to reach numerous significant milestones in its drive to create brands that work in synergy with the company's slogan of 'Plants Heal'. Wildflower's success toward becoming a global wellness brand leader can be seen in its growing distribution network within the United States and its recently announced letter of intent to acquire City Cannabis Co. of Vancouver, British Columbia (

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.

Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.

Gathered within the growing family of Wildflower brands are the following entities:

  • Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
  • King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
  • Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.

Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.

Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.

In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.

Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.

Core Team

William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.

CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.

Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.

Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.

Wildflower Brands Inc. (WLDFF), closed the day's trading session at $0.520224, up 0.55%, on 10,336 volume with 10 trades. The average volume for the last 3 months is 23,194 and the stock's 52-week low/high is $0.009/$1.139.

Recent News


Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN)

The QualityStocks Daily Newsletter would like to spotlight Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN).

Canadian iron ore exploration and development company Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) is advancing its Shymanivske iron ore deposit located in the historically rich Krivyi Rih region of Ukraine at a time that appears favorable for investors as iron ore prices increase and the global appetite for steel remains strong. Black Iron's plans to produce an ultra-high-grade, 68 percent iron ore pellet feed with few impurities at very low cost at its Shymanivske project have been independently reaffirmed by highly regarded market intelligence groups CRU and Wood Mackenzie.

Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) is a Canadian iron ore exploration and development company advancing to production its wholly owned Shymanivske Iron Ore Project, located in Krivyi Rih, Ukraine. Black Iron’s Shymanivske project is situated in the southern part of the historic KrivBass iron ore mining district, a highly developed iron ore mining region with well-established infrastructure and nearby skilled labor forces. Surrounded by seven producing iron ore mines, the Shymanivske project will produce an ultra-high-grade, 68-percent iron ore concentrate with few impurities at very low cost.

The Market

Iron ore concentrates are one of the essential raw materials used by the steel industry to either make sinter or highly valued pellets. Black Iron’s concentrate can be used in either application and is an ideal source to make pellets since it does not need to be ground finer and contains very few impurities. According to the CRU Group, an internationally recognized top global business intelligence provider and consultancy specializing in commodities, there is a growing global shortage of pellet feed resulting in a supply/demand gap of 133Mt against the current base of approximately 400Mt consumed by 2035. According to a recent report issued by Zion Market Research, the global iron ore pellets market was valued at around US$25.22 billion in 2017 and is expected to reach US$50.12 billion by 2024, growing at a compound annual growth rate (CAGR) of 8.1 percent between 2018 and 2024 (

Countries around the world, most notably China (, have instituted regulatory changes to curb polluting emissions from steel mills through numerous methods, including encouraging a shift to higher grade iron feed products such as pellets as less coal needs to be burnt per ton of steel produced.

Shymanivske Project

Black Iron’s Shymanivske’s project, which is expected to produce ultra-high-grade 68 percent iron content pellet feed iron concentrate, is generating significant interest from steel mills and global commodity trading houses. Use of ultra-high-grade 68-percent iron content product in the production of steel is a value-added product to customers since it increases blast furnace productivity and reduces greenhouse gas emissions generated per ton of steel produced.

The project’s proximity to rail lines (1 mile), electrical power (20 miles), sea ports (140 to 260 miles) and a skilled workforce (6 miles) significantly reduces the up-front construction costs and allows for the mine to be built in a phased approach. The Shymanivske project has been ranked by the CRU Group in the lowest position of the business cost curve for pellet feed projects currently under development and as the second lowest in capital intensity (construction capital divided by annual production) within CRU Group’s extensive database ( This low-cost position makes the project economics very robust to any shocks in iron ore price while providing a very high return at current and forecast prices.

Black Iron continues to advance its project on several fronts including construction funding and off-take agreements ( Discussions with Ukraine’s Ministry of Defense to transfer a parcel of land required by the company for location of its processing plant, waste rock and tailings are nearing finalization, as are discussions with the Kryviy Rih City Council to lease a portion of the surface rights currently under that body’s control. The recent engagement of Ivan Markovich as Black Iron’s Vice President of Government and Community Relations will assist the company in these endeavors given his extensive network of relationships with senior Ukraine government officials.

The Shymanivske project holds a mining allotment permit for a large iron ore deposit with a NI 43-101 compliant resource estimated to contain 646 Mt (million tons) Measured and Indicated mineral resources, consisting of 355 Mt Measured mineral resources grading 31.6% total iron and 18.8% magnetic iron, and Indicated mineral resources of 290 Mt grading 31.1% total iron and 17.9% magnetic iron, using a cut-off grade of 10% magnetic iron. Additionally, there are 188 Mt of Inferred mineral resources grading 30.1% total iron and 18.4% magnetic iron.

Full mineral resource details and project economics can be found in the NI 43-101 compliant technical report entitled “Preliminary Economic Assessment of the Re-scoped Shymanivske Iron Ore Deposit” effective November 21, 2017, under the Company’s profile on SEDAR at?


Black Iron’s management and board of directors is stacked with experts well-versed in successfully building and operating iron ore projects. CEO Matt Simpson, P.Eng. is the former general manager of Mining for Rio Tinto’s Iron Core Company of Canada and worked for Hatch designing global metallurgical refineries. He is also a Qualified Person as defined by NI 43-101. Chairman Bruce Humphrey is the former COO of GoldCorp and former chairman of Consolidated Thompson Iron Ore mines which was sold to Cliff’s resources for US$4.9 billion.

Les Kwasik, COO, has over 40 years of hands-on experience building and operating mines globally with companies such as INCO (VALE) and Xstrata (Glencore). Paul Bozoki, CFO, is the former CFO of CD Capital Partners, operating in the Ukraine. Bill Hart, senior vice president of corporate development, has over 30 years of experience selling iron ore while working for Rio Tinto, Cliffs Natural Resources and most recently Roy Hill Holdings Ltd. Ivan Markovich was recently engaged in the capacity of Black Iron’s vice president of Government and Community Relations to leverage his extensive network of relationships with senior Ukraine government officials.

Black Iron Inc. (BKIRF), closed the day's trading session at $0.06, up 4.35%, on 14,000 volume with 2 trades. The average volume for the last 3 months is 56,255 and the stock's 52-week low/high is $0.0285/$0.094.

Recent News


SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

Technology and investment company SinglePoint Inc. (OTCQB: SING) is at a significant reflection point in the company's history as its portfolio investments generate increasing revenues, SinglePoint CEO Greg Lambrecht told shareholders in a sweeping review of the company's recent successes and plans for the future (

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis' SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint's bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout's subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original "Shark Tank" member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet's secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary's product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation's largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint's chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.014, up 9.38%, on 2,946,288 volume with 107 trades. The average volume for the last 3 months is 4,037,301 and the stock's 52-week low/high is $0.0106/$0.068.

Recent News


Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

Marijuana Company of America Inc. (MCOA), an innovative hemp and cannabis corporation, today announces that on May 1, 2019, the Company mailed a letter to its shareholders to update them on recent developments and new business opportunities. In the letter, the Company provided a discussion on its two current acquisitions underway a review of its recent financial and operating performance and details of its new Viva Buds™ brand that will serve as a manufacturing, distribution and retail delivery service for cannabis products in the state of California.

Marijuana Company of America Inc. (OTC: MCOA) (the "Company") are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.0128, up 6.67%, on 20,840,483 volume with 708 trades. The average volume for the last 3 months is 11,467,495 and the stock's 52-week low/high is $0.01025/$0.049.

Recent News


Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF)

The QualityStocks Daily Newsletter would like to spotlight Therma Bright, Inc. (OTC: THRBF).

Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) was featured today in the 420 with CNW by CannabisNewsWire. House Bill 364, a proposed law that seeks to allow patients taking medical cannabis to grow marijuana at home, has been approved by the senate in New Hampshire. The vote was close, but the bill sailed through 14-10.

Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) is a medical device technology provider focused on addressing dermatological needs in the multi-billion-dollar cosmeceutical industry. The company’s effective, non-invasive and pain-free skin care is based on proprietary technology which has received Class II medical device status from the U.S. Food and Drug Administration.

Therma Bright’s portfolio includes products, devices and treatments that have both cosmetic and medicinal or therapeutic benefits, such as for relief of pain, itch and inflammation resulting from more than 20,000 types of insect and marine life bites and stings, including bees, wasps, hornets, mosquitos, black flies and jellyfish.

The Company’s current focus is to market its products online through various social media networks, and to eventually re-establish relationships with major North American and Global retailers.


The company currently has two products on the market and another in the research and development phase:

InterceptCS™ is a thermal therapy device for the treatment and prevention of cold sores caused by the herpes simplex Type 1 virus*. Symptoms typically include sores around the mouth and lips which InterceptCS™ treats by application of controlled topical heat with no risk of burning the skin. When used at the first sign of an oncoming cold sore application of InterceptCS™ can prevent symptoms from developing. Infrared energy and light from the device penetrate the skin killing cells infected with the virus.

InterceptCS™ is available without prescription and comprises a battery powered ergonomic hand-held unit and a disposable single-use treatment activator. Therma Bright has completed prototyping of multi-use activators for InterceptCS™. The company plans to bring to market 5, 10 or 20 multi-use activations at prices that will offer customers greater value than the current single-use activator.

The other Therma Bright product currently under development is TherOZap™, a next generation thermal therapy device powered by the company’s core technology, which is approved by the FDA as a Class II medical device for the relief of the symptoms of insect bites. Therma Bright is testing a new easier-to-use prototype of the device for effectiveness against Zika virus and other diseases carried by mosquitos. Once the technology proves effective, Therma Bright intends to seek regulatory approvals and extend the prototype enhancements to a new commercial version of TherOZap™.


Therma Bright is also conducting research and development on a unique thermal therapy device that would incorporate medical grade cannabis or cannabidiol (“CDB”) sourced from hemp as a cream or gel to provide relief of back, knee and other joint pain. In preparation, the company has incorporated a wholly owned subsidiary to hold any technology for use or application of cannabis. Once approvals are secured, the company plans to sell the device through licensed cannabis producers or retailers across Canada and in international markets where use of cannabis has been legalized. The company has initiated trademark and patent protection for its thermal therapy technology incorporating medical cannabis. Therma Bright has indicated it will seek an acquisition to help further development of this product.

Market Opportunity

A report by market intelligence firm Mordor Intelligence put the global cosmeceuticals market at a value of nearly US$47 billion in 2017 and projects it to be worth more than $80 billion by 2023, growing at a rate of almost 9.5 percent annually. Medical research estimates that somewhere between 20 percent and 40 percent of the population suffer occasional cold sore outbreaks. In Canada those figures would mean five to 10 million people, and in the U.S. some 40 million to 80 million, with recurring cold sores, representing a substantial potential market for Therma Bright.


Rob Fia serves as Therma Bright chairman and CEO. Fia has extensive contacts in the investment community and the financial sector as well as knowledge of various Canadian stock exchange listing processes and requirements. His 18 years in the investment business has included equity research and advising promising early stage companies on corporate finance. Therma Bright CFO Victor Hugo is a senior financial analyst at Marrelli Support Services Inc., for which he provides CFO, accounting, regulatory compliance, and management advisory services to companies listed on the TSX, TSX Venture Exchange and other Canadian and US exchanges.

**Based on double blind placebo study, the InterceptCS™ is approved by Health Canada for the claim “For prevention of cold sores when used within 3 hours of the onset of the prodrome.” The InterceptCS™ is not approved by the United States FDA or any claim of clinical indication, clinical efficacy, and/or cure or prevention of disease.

Therma Bright, Inc. (OTC: THRBF), closed the day's trading session at $0.0254, even for the day. The stock's 52-week low/high is $0.0098/$0.029.

Recent News


TransCanna Holdings Inc. (CSE: TCAN)

The QualityStocks Daily Newsletter would like to spotlight TransCanna Holdings Inc. (CSE: TCAN).

TransCanna Holdings Inc. (CSE: TCAN) was featured today in the 420 with CNW by CannabisNewsWire. House Bill 364, a proposed law that seeks to allow patients taking medical cannabis to grow marijuana at home, has been approved by the senate in New Hampshire. The vote was close, but the bill sailed through 14-10.

TransCanna Holdings Inc. (CSE: TCAN) through its subsidiaries specializes in assisting clients who are cannabis farmers and manufacturers get recognized by end consumers who in turn purchase their products. TransCanna offers or will be offering services to support almost every aspect of the cannabis-related eco-system; from branding and design, to transportation and distribution, to marketing and sales.

California’s legalized adult-use recreational marijuana market opened for business January 1, 2018. The state’s Bureau of Cannabis Control is responsible for regulating all commercial activities in the state including cultivation, distribution and transportation. Moving cannabis products in the California marketplace is extremely challenging due to municipal and state laws and regulations, which can differ among cities and counties. Since cannabis remains illegal under federal law, Department of Transportation regulated companies are barred from participating in the market, which means companies looking to excel in the sector must hold a state-issued distributor license from the Bureau of Cannabis Control.

TransCanna has already entered into an Intellectual Property Rights and Royalty Agreement for the Track & Trace software platform required by the state of California. TCM Distribution, the operating company managed by TransCanna, has received a transportation and distribution permit from the city of Adelanto and a temporary transportation and distribution permit from the state of California. TransCanna has also executed a land lease to build a 10,000-square-foot transportation and distribution facility in Adelanto.

TransCanna is strategically creating a distribution network throughout California that places its facilities no further than a three-hour drive from most any client. The company is in the process of leasing or purchasing properly licensed and permitted warehouses strategically located throughout California along with new secure trucks, sprinter vans and/or armored vehicles.

TransCanna plans to create its own portfolio of branded products for the cannabis and hemp sectors. The company’s management team intends to translate the skills, knowledge and experience gained from a combined 60 years of branding and marketing experience in the music, professional sports and alcohol industries into TransCanna and the cannabis industry.

As part of the “TransCanna Way,” the company intends to manage most aspects of the supply chain from upper end procurement, branding, transportation and distribution, to marketing and sales.

Leading TransCanna as its CEO and chairman is James Pakulis, who has three decades of experience working with public and private entrepreneurial companies in a variety of emerging and high-growth sectors. He is formerly the president and a director of Lifestyle Delivery Systems Inc. (CSE: LDS) (OTCQB: LDSYF), a vertically integrated cannabis-related entity operating in California. Pakulis was chairman and CEO of General Cannabis Inc. which from 2010 to 2012 owned WeedMaps. Pakulis oversaw the company’s growth from zero to over $16 million in annual revenue in less than 24 months.

The company’s strategic advisors include individuals with extensive experience in branding, marketing, sales, distribution, production and supply chain management.

For additional information, call: (604) 609-6199

TransCanna Holdings Inc. (CSE: TCAN), closed the day's trading session at $6.05, off by 10.24%, on 269,436 volume with 398 trades. The average volume for the last 3 months is 162,060 and the stock's 52-week low/high is $0.77/$7.79.

Recent News


The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) this morning announced its plans to release the company's first quarter 2019 earnings after market close on May 14, 2019. According to the update, the company will host a conference call at 9:00 AM ET on May 15, 2019, conducted by CEO Brian Athaide and CFO Sean Bovingdon, to discuss the first quarter 2019 results and future outlook. To view the full press release, visit:

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $3.17, off by 1.86%, on 579,048 volume with 831 trades. The average volume for the last 3 months is 1,242,701 and the stock's 52-week low/high is $1.607/$7.894.

Recent News


Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) this morning announced its entry into a definitive 5-year agreement, via its subsidiary Lexaria Hemp Corp. To view the full press release, visit:

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECHTM technology to improve taste, remove odor, and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada, the largest-market states in the United States, and internationally. Lexaria has entered into a R&D partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea, and supplements. These brands include ViPova™ and TurboCBD™.

In 2015, Lexaria commissioned an independent third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation improve intestinal absorption as much as 500%. Lexaria has conducted multiple rounds of studies including in vivo and human clinical. In absorption studies conducted on rats, for example, Lexaria detected nicotine in the animal’s bloodstream just two minutes after it entered the stomach. In a randomized, double blinded human clinical study, cannabidiol (CBD) was measure in the human bloodstream at a 317% higher rate 30 minutes after swallowing a capsule processed with DehydraTECH than a non-enhanced capsule of equal strength.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: Hemp/CBD; Pharmaceutical; Cannabis; and Nicotine.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the end of 2018, the company’s patent portfolio includes 53 patent applications filed and pending in more than 40 countries around the world; and 10 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally in 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third-partners and has signed royalty deals with start-up companies as well as with a Fortune 100. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $0.9606, off by 2.47%, on 91,158 volume with 85 trades. The average volume for the last 3 months is 117,159 and the stock's 52-week low/high is $0.75/$2.43.

Recent News


Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF)

The QualityStocks Daily Newsletter would like to spotlight Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF).

Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF) was featured today in a publication from examining how sales of cannabidiol (CBD) oil are dramatically rising across North America, as its availability on mainstream shelves caters to growing health, wellness, and beauty markets. Much of this growth is being driven at two ends of the age spectrum, as hemp-based CBD is becoming more and more popular among both baby boomers and millennials.

Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF), an investment company focused on the U.S. and international cannabis sectors, provides turnkey solutions for the regulated cannabis industry. The company leverages managements' expertise and decades of experience in the cannabis industry to acquire and develop vertically integrated cannabis assets. Chemistree recently closed on a purchase of prospective cannabis cultivation property in California, made a first investment in the Canadian cannabis industry, owns assets in the State of Washington used to operate an established retail cannabis brand, and has an active pipeline of assets in place to grow its portfolio.

Chemistree offers industry leading expertise across all areas the cannabis business and in its growth as a public or private company.

  • Investment and funding for rapid growth
  • Vertical integration solutions
  • Construction, design and/or optimization of indoor or outdoor cultivation facilities
  • Reputation management & influencer outreach
  • Branding and Packaging
  • Social Media and Media outreach

With the marketing of cannabis companies and their products in its infancy, the company believes the industry offers tremendous opportunity for growth in the U.S. and abroad. Chemistree initially targeted the Pacific Northwest for investment and, following its recent California property purchase, expects to expand vertically across the United States in areas where it has a competitive business advantage.

Through its wholly owned CHM Desert LLC subsidiary, Chemistree owns 9.55 acres of undeveloped land in Desert Hot Springs, California. The property is zoned as Light Industrial Lands Designated for Marijuana Cultivation, and local zoning ordinances allow as a conditional use the location of up to three onsite cannabis cultivation buildings of 68,000 square feet each, along with support space that would support production of 55,000 pounds/year.

Through its wholly owned Chemistree Washington Ltd. subsidiary, Chemistree acquired physical assets used in the cultivation, production and distribution of cannabis. The Washington assets are currently under lease to Sugarleaf Farm LLC, which operates the Sugarleaf brand of retail cannabis products in the State of Washington. Sugarleaf Farm is a Tier 3 cannabis producer and processor whose products are sold in about 125 retail outlets. Chemistree has indicated the relationship with Sugarleaf may provide the company with additional opportunities to become involved in the marketing of Sugarleaf products.

Chemistree funded these acquisitions and investments with the proceeds of two non-brokered private placement financings completed earlier this year under the regulations of the Canadian Securities Exchange, totaling CAD$4.5 million. In conjunction with the private placements, the company was granted approval by the CSE for a change of business to become an Investment Issuer. This funding is expected to provide the company "maximum flexibility to take advantage of the numerous opportunities available in the cannabis industry in Canada and the U.S."

Chemistree also has a strategic investment in Pasha Brands Ltd., a British Columbia based cannabis company with multiple internationally recognized brands. Pasha has a proven history in cannabis retailing and its proposed Licensed Processing (LP) facility on Vancouver Island is in the final stage of the application for government approval. The LP facility is expected to assist in licensing selected craft growers of cannabis and expanding the distribution of locally grown product. The investment represents less than 10% of Chemistree's working capital.

Company Chairman Justin Chorbajian is co-owner of the largest chain of privately owned hydroponic retail shops in Canada. He also cofounded a group of companies that manufacture and distribute hydroponic equipment. He is a frequent contributor to Growing Exposed, the leading video series dedicated to cannabis cultivation. Company President Karl Kottmeier is a former investment advisor with 20 years of experience listing, financing and administering companies on the Toronto Stock Exchange and TSX Venture Exchange. He has raised more than $150 million in equity capital for ventures. Chemistree CFO Doug Ford has been general manager of Dockside Capital Group Inc., a private merchant banking and venture capital firm serving emerging growth companies. Sheldon Aberman, the most recent member of the Board, has managed, designed and created industry leading grow room designs around the world. Additionally, he has built several leading brands such as Frost Box and Black Label and is an expert in the accessory market (vape pens, silicon mats and extraction tools etc.).

Data firm Statista has forecast the U.S. legal cannabis market will be worth more than $24 billion by 2025. New Frontier Data, which focuses exclusively on the cannabis industry, projects the value of the Canadian domestic cannabis market that same year at CAD$9.2 billion.

Chemistree Technology Inc. (CHMJF), closed the day's trading session at $0.4776, off by 0.50%, on 201,063 volume with 135 trades. The average volume for the last 3 months is 73,501 and the stock's 52-week low/high is $0.268/$0.605.

Recent News


Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P)

The QualityStocks Daily Newsletter would like to spotlight Nabis Holdings (OTC: INNPF).

Innovative Properties Inc. d/b/a Nabis Holdings (CSE: NAB; OTC: INNPF; FRA: 71P) ("Nabis" or the "Company"), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, today announced that Shay Shnet, CEO & Director of Nabis and Mark Krytiuk, President will present at the Canaccord Genuity 3rd Annual Cannabis Conference to be held at the Grand Hyatt New York in New York, NY on Tuesday, May 14, 2019 at 2:40pm ET.

Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P), dba Innovative Properties Inc., is a Canadian investment company pursuing interests in high-quality cash-flow assets in real property, securities, cryptocurrency and all branches of the cannabis sector. The company's focus on strategic revenue generation, EBITDA and growth is enshrined in its moto, "One team. One goal," and is reflected in its name: "Na bis," which is defined as, "repeat performance" or "encore."


While the Nabis' targets span numerous industries, the company aims to establish an Anchor Investment Portfolio primarily through the acquisition of majority interests in high quality U.S. cannabis assets and brands that have achieved cash flow. The company will then employ a hands-on approach to assist the investee in implementing standards and consistency to enhance their operations.

Criteria for investment targets are as follows:

  • Positive EBITDA, vertically integrated operators in limited license states with large addressable markets
  • Emphasis on operations that add material EBITDA within 12 months with enhanced access to capital and Nabis' value add approach on operations and brand consistency
  • Identifying proven operators with good expertise to add value to a consolidation strategy
  • Focused on MSOs (Multi-state Operators) with strong brand traction
  • Pharma grade cultivation, extraction, dispensaries and other addressable operations

Current Endeavors

Nabis has completed investments in five Michigan properties with Cannabis provisioning, processing and cultivation licenses. The Company has also entered into binding Letters of Intent ("LOI") to invest in vertically integrated assets in Michigan, Arizona and Washington State. The company's goal is to be invested in four to five additional states in the coming months.

Arizona – LOI to acquire full control of Organica Patient Group Inc. ("OPG") and RDF Management Group. OPG is a fully integrated medical marijuana business licensed under the provisions of the Arizona Medical Marijuana Act. Its assets include the Chino Valley MMJ Dispensary and fully established Patient Group, which since 2012 has operated as "Organica Patient Group" in Chino Valley. OPG also operates a 26,000-square-foot indoor cultivation and processing center along with a 56,600-square-foot greenhouse in Prescott Valley; has its own branded products and wholesale operations which includes distribution to more than 25% of the dispensaries in Arizona; and has exclusive manufacturing and licensing agreements with Fire Brand, Gas Extracts and Donuts Concentrate products distributed within Arizona.

Michigan – LOIs to invest in multiple strategically located properties that have or are eligible for municipal approvals for provisioning centers in Michigan. The company is currently evaluating 10 to 15 additional municipally approved locations in Michigan that would substantially increase the company's overall presence in the U.S. cannabis space.

Washington State – LOI to purchase assets from PDT Technologies LLC, including extraction and production equipment and rights to lease the current production facility in Port Townsend, Wash. The LOI includes licensing rights to produce Chong's Choice Brand CO2 Vape Cartridges, one of the leading and most recognizable brands in the cannabis space. Expansion plans include construction of a new ISO designed extraction clean room and GMP lab facility with new, highly specialized equipment with two extraction lines. The facility could produce up to 20,500 kg of cannabis concentrate on an annual basis.

Hivemind Refinery – LOI to invest in a 70% interest of Hivemind Refinery, an established line of CBD-based wellness products in the United States. The investment into Hivemind expands Nabis' investment portfolio to CBD edibles, water, drops, lotions, and other CBD wellness products across the spectrum. Nabis anticipates Hivemind will be a premium consumer CBD line to be distributed across the U.S. and Canada and will focus on products utilizing locally grown, premium CBD along with unique formulations and delivery systems.

Bloombox – binding term sheet with Momentum Ideas Co. to acquire certain assets used and marketed under the brand "Bloombox," a leading intelligent retail cannabis software platform that includes the Bloombox Software and data platform. The acquisition of Bloombox will create a dominating presence in the U.S. cannabis market, featuring an integrated ecosystem of modern, next-generation cannabis technology. Bloombox is one of the world's first standards-based cannabis software systems, enabling frictionless integration with nearly any business system or regulatory body.

Proven Management Team

CEO and Director Shay Shnet has over 20 years of experience in business and was most recently a founding partner and vice president of operations of MPX Bioceutical (CSE: MPX). While at MPX, Shnet focused on the North American cannabis space and helped build the company's portfolio of international cannabis assets. He is highly skilled in finding unique opportunities and has been directly involved with the development, branding, importing, consumer packaging and distribution of a wide variety of product lines.

President Mark Krytiuk is a very successful cannabis operator and was a founding partner of MPX. As the vice president of grow operations of MPX, he oversaw the production of medical marijuana and pharma-grade products across North America. He has been directly involved in overseeing the rapid expansion and buildout of nine facilities in three countries with budgets ranging up to $30 million. Krytiuk's experience includes consulting and working with customers to develop individual requirements for indoor and outdoor cannabis cultivation while working with federal regulators and licensing bodies to ensure compliance.

Nabis Holdings (OTC: INNPF), closed the day's trading session at $0.464, off by 3.33%, on 105,705 volume with 50 trades. The average volume for the last 3 months is 422,690 and the stock's 52-week low/high is $0.417/$0.791.

Recent News


QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ)

The QualityStocks Daily Newsletter would like to spotlight QMC Quantum Minerals Corp. (QMCQF).

The current evolution in computer and vehicle technology, fueled by the lightweight lithium-ion battery, is igniting interest in new lithium production. This has led mineral explorer QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) to push forward, as it continues developing a NI 43-101-compliant resource estimate as the next step toward potential commercial production of lithium at its Irgon Dike in southeast Manitoba.

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.

QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.

The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.

North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.

The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.

QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens,  and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.

The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.

QMC Quantum Minerals Corp. (QMCQF), closed the day's trading session at $0.16, off by 0.62%, on 30,500 volume with 14 trades. The average volume for the last 3 months is 52,579 and the stock's 52-week low/high is $0.1155/$0.512.

Recent News


Spectrum Global Solutions, Inc. (SGSI)

The QualityStocks Daily Newsletter would like to spotlight Spectrum Global Solutions, Inc. (SGSI).

Via its subsidiaries, Spectrum Global Solutions Inc. (OTCQB: SGSI) is a foremost single-source provider of end-to-end, next-generation wireless and wireline network infrastructure and professional service solutions. The company owns and operates a number of subsidiaries that allow it to provide wide-ranging services encompassing all facets of fiber, wireline and wireless networks and associated critical infrastructure. With headquarters in Longwood, Florida, Spectrum has completed over 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States using licensed professional engineers, project managers, technicians and general contractors (

Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:

  • AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
  • ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
  • Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.

Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.

Market Opportunity

Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.


CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.

Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.

Spectrum Global Solutions, Inc. (SGSI), closed the day's trading session at $0.109, off by 18.66%, on 8,001 volume with 5 trades. The average volume for the last 3 months is 109,239 and the stock's 52-week low/high is $0.071/$2.59.

Recent News


VPR Brands, LP (VPRB)

The QualityStocks Daily Newsletter would like to spotlight VPR Brands, LP (VPRB).

VPR Brands LP (OTC: VPRB), a market leader specializing in vaporizers and accessories for essential oils, cannabis concentrates and extracts (CBD), as well as electronic cigarettes containing nicotine, today announced its 2018 full-year financial results, posting increased revenues and a narrowed net loss as compared to 2017.

Florida-based VPR Brands, LP (VPRB) is an innovative technology holding company whose assets include patented atomization-related products and technology. VPR Brands' current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.

VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty. The company's current product portfolio is comprised of the following:

  • GoldLine combines premium ingredients and extracts coupled with the newest in technology to achieve the ultimate selection of cannabidiol (CBD) and hemp-based products available anywhere. The product range is designed for a wide variety of consumers and features edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. For more information please visit?
  • HoneyStick is a lifestyle brand that combines the features of high tech, high performance, dependability and affordability when it comes to upper tier vaporizers. HoneyStick was first to market in creating a Sub Ohm vaporizer to the latest Ripper and Plasma GQ. The HoneyStick team works with a vast network of growers, extractors and industry figures to bring the needs of patients and recreational users to life. HoneyStick is sold online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops. For more information about HoneyStick, visit?
  • Helium brings the vaping experience to a new level with intense flavors that are steeped to perfection and chilled at 20 degrees below room temperature. Helium's chillers are scientifically proven to preserve flavor, freshness and aroma. Helium is in a 50ml durable and squeezable bottle with drip tip that is functional from the start, engineered to deliver 77 percent VG.
  • Vaporin delivers Sub Ohm series starter kits. Vaporin also provides an eye-catching display case with multi-packs of selected starter kits, coils and premium e-liquids for retail and dispensary operations.
  • Vaporx offers the most current, highest quality products from the best-known brands, including KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech, Samsung. Vaporx acts as an extension to a client's purchasing department, providing the option to schedule regular product mix refresh for maximum sales.
  • GoldLine Hemp products are developed specifically for the convenience store market segment. GoldLine Hemp-only products are created without CBD, providing an alternative product line for consumers who are not ready to experience CBD products but still want to take advantage of this rapidly expanding class of products. GoldLine Hemp-only edible Hemp Gummies debuted at the National Association of Convenience Stores (NACS) Expo in Las Vegas in October 2018 and are now being distributed nationwide. The U.S. convenience store industry, with more than 154, 000 stores nationwide, serves 160 million customers daily and has sales that are 10.8% of the total U.S. retail and food service sales. Visit? more information about GoldLine Hemp-only products.
  • Vapor Store Direct in Fort Lauderdale, Florida, is one of the largest vaporizer and e-liquid wholesalers in the United States. Vapor Store Direct stocks internationally elite brands, vaporizers, tanks/atomizers, coils, e-liquid, e-cigarettes, batteries, glass and accessories.

Management Team

CEO Kevin Frija is a veteran entrepreneur with nearly 30 years of experience in sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. In 2009, Frija became the president and chief executive officer of Vapor Corp., one of the first U.S. importers and publicly traded electronic cigarette companies. In 2016, Frija purchased the brands and wholesale business assets from Vapor Corp., which is now owned by VPR Brands. Under his leadership, VPR Brands is pivoting toward cannabis products which is increasing sales and profit margins.

Dan Hoff, chief operating officer, has worked in the vaporizer and e-cigarette industry, serving in various positions at Vapor Corp., including overseeing the financial management, accounting functions, supply chain management, product design and development, and key vendor relations. He has played a pivotal role in building and expanding the cannabis-based products division at VPR Brands, which includes a turnkey OEM vapor solutions program available to farmers, cultivators and extractors. Hoff received his bachelor's degree from the University of Miami School of Business.

VPR Brands, LP (VPRB), closed the day's trading session at $0.06, off by 13.98%, on 144,641 volume with 13 trades. The average volume for the last 3 months is 85,231 and the stock's 52-week low/high is $0.026/$0.14.

Recent News


The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.